Maryland committees hear hours of testimony on House Bill 1328, End of Life Option Act

A joint hearing of the House Health and Government Operations Committee and the Judiciary Committee examined House Bill 1328, the End of Life Option Act, which would let mentally capable adults with a terminal diagnosis obtain and self-administer prescribed medication to end their life.

Sponsor Delegate Terry Hill, a physician, opened her presentation by framing the bill as an option for a narrow group of patients and stressing patient autonomy. "I highly value life, and I highly value life with dignity and the dignity of death," Hill said, and she described the bill's principal safeguards, including oral and written requests, witness rules, a consulting-physician review and a mental-health referral when capacity is in question.

Why it matters: proponents said the bill offers terminally ill patients a protected way to avoid what some described as prolonged, undignified dying; opponents said the measure risks coercion of vulnerable people, could complicate involuntary psychiatric-treatment laws and would create operational problems for hospice providers and pharmacies.

What the bill requires (as described by the sponsor): a qualified patient must make an initial oral request to an attending physician, then a second oral request at least 15 days later; the patient must also submit a signed written request witnessed by two people (only one witness may be a relative and the attending physician cannot be a witness). The attending physician must confirm capacity, the diagnosis and the prognosis; if capacity is in doubt either the attending or consulting physician must refer the patient to a licensed mental-health professional and obtain written confirmation of competency before proceeding. Hill also emphasized that a patient may withdraw the request at any time and is not required to take medication once it is prescribed and dispensed.

Supporters: Dozens of witnesses testified in favor, including patients and clinicians. Cancer patient Lynn Cave told the committees her experience as a person with metastatic disease and said the option would be "a kindness" for those who face unrelieved suffering: "Having the promise of a dignified death on my own terms is my greatest comfort for what lies ahead." Retired obstetrician-gynecologist Dr. Janice Byrd said physicians should be permitted to participate voluntarily and described aid in dying as an ethically defensible option for a minority of patients whose pain and suffering are not relieved by other measures. Other proponents invoked interstate experience, peer-reviewed studies and polls showing majority public support in Maryland.

Opponents: Physicians, disability advocates, hospice staff, faith leaders and others testified against the bill. Dr. Annette Hanson, a forensic psychiatrist speaking for the Maryland Psychiatric Society, said she was concerned the measure "will create and confusion regarding our involuntary mental health treatment laws" and described scenarios in which hospital or prison patients might present legal and ethical conflicts if the policy were enacted. Hospice and nursing witnesses raised operational concerns about staff presence during self-administration and cited reports of complications (vomiting, seizures) following ingestion of prescribed lethal regimens. Pharmacists warned that the compound used in some jurisdictions requires specialized compounding and safe-handling protocols.

Themes in the hearing: proponents emphasized autonomy and the availability of safeguards (two physicians, witnesses, waiting periods, and optional mental-health evaluations), and several medical witnesses and affected family members described cases in other states where they said the process provided relief or dignity. Opponents stressed risks to vulnerable populations — people with disabilities, the elderly, patients with cognitive impairment — and raised legal and practical questions about detention settings and the potential chilling effect on clinicians employed by state facilities. Disability advocates and faith leaders warned the bill could be perceived as valuing some lives less than others and urged continued investment in palliative and supportive care.

Data and evidence cited: witnesses referenced experience in states that permit medical aid in dying, two studies (Hawaii and University of California–San Francisco) about the accuracy of clinician capacity assessments, AHRQ comments and reporting recommendations from disability groups (The Arc Maryland). Several witnesses also pointed to state reporting data and contested whether those data show increases in overall suicide rates or differential access across racial and socioeconomic groups; witnesses disagreed on interpretation.

Process and next steps: the hearing collected testimony but did not include a committee vote. Hill said she is open to amendments suggested by advocates and agencies, including clarifying language about consulting physicians not being in the same practice as the attending physician and specifying additional reporting fields for the Department of Health.

The hearing record will continue to be part of the committee process; sponsors and opponents indicated they expect further negotiation over reporting requirements, pharmacist protections and explicit limits to prevent advance directives or use by incapacitated individuals.

Sources: testimony and exchanges before the House Health and Government Operations Committee and the Judiciary Committee during the HB 1328 hearing, including statements by Delegate Terry Hill, Lynn Cave, Dr. Janice Byrd, Dr. Annette Hanson and multiple advocates and faith leaders.